Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Creo Medical ( (GB:CREO) ).
Creo Medical Group plc announced the retirement of John Bradshaw, its Senior Independent Non-Executive Director, who has been with the company since its IPO in 2016. Ivonne Cantu will serve as interim Audit Committee chair, while Brent Boucher will take over as Remuneration Committee chair. These changes are part of Creo’s ongoing efforts to strengthen its governance framework and ensure a smooth leadership transition.
More about Creo Medical
Creo Medical Group plc is a medical device company specializing in the development and commercialization of minimally invasive electrosurgical devices. The company focuses on enhancing surgical endoscopy for pre-cancer and cancer patients through its advanced CROMA technology powered by Kamaptive, which integrates multi-modal energy sources to optimize surgical outcomes.
Average Trading Volume: 1,257,002
Technical Sentiment Signal: Sell
Current Market Cap: £41.87M
For detailed information about CREO stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue